(PRESS RELEASE) VALENCIA, 21-Jan-2026 — / EuropaWire / — Prosolia Energy has expanded its renewable energy platform with the acquisition of a 229-megawatt portfolio of solar assets in Spain from EDP ...

Empa has developed polymer-based, MRI-compatible electrode cables in collaboration with Swiss company TI Solutions AG, addressing long-standing safety and performance challenges associated with using ...

Continental has introduced the Terra Adventure Graphite-Reflex, a new gravel tire variant featuring a reflective sidewall strip to improve visibility in low-light conditions. Retaining the aggressive, ...

The Luxembourg Stock Exchange has acquired the ESG data analytics unit of fintech Tetrao International, enhancing its sustainable bond data capabilities and reinforcing its leadership in sustainable ...

The 605 MW offshore wind farm Greater Changhua 1 is co-owned by Ørsted (50 %) as well as Caisse de dépôt et placement du Québec (CDPQ) and Cathay PE, who have a combined ownership stake of 50 %.

EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...

Lloyds Banking Group has launched an AI Academy to provide practical AI training for all 67,000 employees, regardless of role or experience. Delivered through flexible, bite-sized learning, the ...

The divestment forms part of WestInvest InterSelect’s active portfolio management strategy, allowing the fund to capitalize on strong investor demand for high-quality hotel assets in Mallorca. The ...

NIB has provided a €50 million, seven-year loan to TDC NET A/S to finance fibre broadband network rollout investments in Denmark during 2025–2027, with a focus on the Greater Copenhagen area. The ...

VINCI Construction has agreed to acquire Fletcher Construction, a New Zealand infrastructure specialist employing 2,300 people and generating around €630 million in annual revenue. Subject to ...

GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...

GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, ...